Alendronate Sandoz

Alendronate Sandoz

alendronic acid




Zuellig Pharma
Concise Prescribing Info
Alendronate Na
Treatment of postmenopausal osteoporosis. Reduces the risk of vertebral & hip fractures. Treatment of osteoporosis in men to prevent fractures. Treatment & prevention of glucocorticoid-induced osteoporosis in postmenopausal women not receiving estrogen.
Dosage/Direction for Use
1 tab once wkly.
Should be taken on an empty stomach: Take at least 30 min before the 1st food/drink/medication of the day w/ a full glass of plain water & remain in sitting/upright position for at least 30 min. Swallow whole, do not chew/crush.
Abnormalities of the esophagus & factors that delay esophageal emptying eg, stricture or achalasia. Inability to stand or sit upright for 30 min. Hypocalcemia.
Special Precautions
Active upper GI problems eg, dysphagia, esophageal disease, gastritis, duodenitis, ulcers, history of major GI disease eg, peptic ulcer, or active GI bleeding, or surgery of upper GIT. Renal impairment. Disorders affecting mineral metabolism. Ensure adequate Ca & vit D intake.
Adverse Reactions
GI effects eg, abdominal pain, dyspepsia, acid regurgitation, nausea, abdominal distension, constipation, diarrhea, dysphagia, flatulence, esophageal ulcer. Musculoskeletal pain, muscle cramp. Headache.
Drug Interactions
Ca supplement, antacids, food & beverages, some oral medicinal products may interfere w/ alendronate absorption if taken at the same time.
ATC Classification
M05BA04 - alendronic acid ; Belongs to the class of bisphosphonates. Used in the treatment of bone diseases.
Alendronate Sandoz FC tab 70 mg
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in